Active Ingredient History

NOW
  • Now
Methylphenidate is a CNS stimulant approved for the treatment of narcolepsy and attention deficit hyperactivity disorder. The drug is believed to bind the dopamine transporter in the presynaptic cell membrane, thereby blocking the reuptake of dopamine and causing an increase in extracellular dopamine levels.   NCATS

More Chemistry

Drug Pricing (per unit)

Australia

$0.0709 - $1.4242

United States

$0.0961 - $377.9334
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

5,10-dihydro-5-methylphenazine | 5,10-dihydro-5-methylphenazine, radical ion (+) | alpha-phenyl-2-piperidineacetic acid methyl ester | calocain | concerta | daytrana | delmosart | equasym | equasym xl | hld200 | matoride xl | medikinet | medikinet xl | metadate cd | metadate er | methelphenidate | methyl alpha-phenyl-alpha-2-piperidinylacetate | methyl alpha-phenyl-alpha-(2-piperidyl)acetate | methylin | methylin er | methylphenidan | methylphenidate | methylphenidate hcl | methylphenidate hydrochloride | methylphenidatum | methyl phenidylacetate | metilfenidato | mph | phenidylate | quillivant xr | ritalin | ritalin la | ritalin sr | tranquilyn | xenidate xl

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue